Bio-Rad Laboratories Inc. (BIO)
NYSE · Healthcare
Bio-Rad Laboratories Inc. Income Statement 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenue | 2.58B | 2.57B | 2.67B | 2.80B | 2.92B | 2.55B | 2.31B | 2.29B | 2.16B | 2.07B | 2.02B | 2.18B | 2.13B | 2.07B | 2.07B | 1.93B | 1.78B | 1.76B |
| Gross Profit | 1.34B | 1.38B | 1.43B | 1.57B | 1.64B | 1.44B | 1.26B | 1.22B | 1.19B | 1.14B | 1.12B | 1.18B | 1.18B | 1.16B | 1.18B | 1.09B | 999.8M | 962.5M |
| Profitability | ||||||||||||||||||
| Operating Income | 47.2M | 269.0M | 337.8M | 482.6M | 500.3M | 421.3M | 229.7M | -103.3M | 119.3M | 55.7M | 166.7M | 150.0M | 169.5M | 264.2M | 305.2M | 284.0M | 231.0M | 182.9M |
| EBITDA | 212.6M | 420.6M | 483.7M | 619.9M | 637.9M | 559.9M | 363.9M | 34.8M | 267.9M | 198.6M | 298.5M | 299.9M | 316.7M | 394.6M | 426.2M | 392.9M | 332.7M | — |
| Net Income | 759.9M | -1.84B | -637.3M | -3.63B | 4.25B | 3.81B | 1.76B | 365.6M | 122.2M | 26.0M | 109.2M | 88.8M | 77.8M | 165.5M | 179.0M | 185.5M | 144.6M | 89.5M |
| Per Share Data | ||||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 27M | 28M | 29M | 30M | 30M | 30M | 30M | 30M | 30M | 30M | 29M | 29M | 29M | 29M | 28M | 28M | 28M | 28M |
Bio-Rad Laboratories Inc. Income Statement — FAQ
Bio-Rad Laboratories Inc. (BIO) income statement over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIO's income statement history?
The chart and table above show Bio-Rad Laboratories Inc.'s income statement by year and by quarter, including the growth rate.